M&A Activity Will Continue to Support Market Sectors, ETFs in Next Rate Hike | Page 2 of 2 | ETF Trends

“The consumer space increasingly active and of course the healthcare space – healthcare broadly defined – pharmaceutical, equipment, services, the whole healthcare space undergoing a lot of scrutiny in terms of deals and just started to see the beginning of a lot of activity in chemicals,” Studzinski added.

Deals in the pharmaceutical, medical and biotech space is also at an all-time year-to-date high.

Additionally, the PowerShares Dynamic Biotechnology & Genome Portfolio (NYSEArca: PBE), BioShares Biotechnology Clinical Trials Fund (NasdaqGM: BBC) and ALPS Medical Breakthroughs ETF (NYSEArca: SBIO) have all benefited from their tilt toward smaller biotech names that are developing new targeted treatments. [ETFs for the Next Biotech Takeover Targets]

For more information on the market sectors, visit our sector ETFs category.

Max Chen contributed to this article.